Chemotherapy Treatment in Re-occurring Non Small Cell Lung Cancer (NSCLC) After Previous Chemotherapy and Surgical Removal of the NSCLC Tumor
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
Ifosfamide, Carboplatin, Etoposide, and SGN-30 in Treating Young Patients With Recurrent Anaplastic Large Cell Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Phase II Study of Radiation Therapy, Paclitaxel Poliglumex, and Carboplatin in Stage III Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Vinblastine and Carboplatin in Treating Young Patients With Newly Diagnosed or Recurrent Low-Grade Glioma
- Status
- COMPLETED
- Phase
- PHASE1
ATN-161 and Carboplatin in Treating Patients With Recurrent Malignant Glioma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Fallopian Tube, Primary Peritoneal, or Carcinosarcoma Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Pemetrexed/Carboplatin Non-Small Cell Lung Cancer (NSCLC) Elderly Patients
- Status
- COMPLETED
- Phase
- PHASE2
Study of NOV-002 in Combination With Chemotherapy to Treat Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy of NOV-002 in Combination With Carboplatin in Chemotherapy-resistant Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma
- Status
- COMPLETED
- Phase
- PHASE3
Vincristine, Carboplatin, and Etoposide or Observation Only in Treating Patients Who Have Undergone Surgery for Newly Diagnosed Retinoblastoma
- Status
- COMPLETED
- Phase
- PHASE3
Combination Chemotherapy, Radiation Therapy, and/or Surgery in Treating Patients With High-Risk Kidney Tumors
- Status
- COMPLETED
- Phase
- PHASE2
Radiation Therapy, Chemotherapy, and Bevacizumab in Treating Patients With Recurrent, Unresectable or Stage III or Stage IV Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Pelvic IMRT With Tomotherapy in Post-Hysterectomy Endometrial Cancer Patients
- Status
- COMPLETED
- Phase
- PHASE1
Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Alimta, Carboplatin and Radiation Therapy for Non Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Sorafenib, Carboplatin, and Paclitaxel in Treating Patients With Stage IV Melanoma of the Eye
- Status
- COMPLETED
- Phase
- PHASE2
Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin vs Carboplatin/Paclitaxel) in Patients With Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE3